Duraibabu Prathyusha (CIK 1779092) reported 8 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-02-20). Recent activity: Buy ORGO (48,828 shares), Sell SGMO (36,676 shares), Sell SGMO (2,544 shares), Sell SGMO (45,225 shares), Sell SGMO (1,792 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-20 | Organogenesis Holdings Inc. (ORGO) | Director | Buy | 48,828 | $0 |
| 2026-01-26 | SANGAMO THERAPEUTICS, INC (SGMO) | PRINCIPAL FINANCIAL OFFICER | Sell | 36,676 | $14,670 |
| 2025-11-26 | SANGAMO THERAPEUTICS, INC (SGMO) | PRINCIPAL FINANCIAL OFFICER | Sell | 2,544 | $1,068 |
| 2025-10-24 | SANGAMO THERAPEUTICS, INC (SGMO) | PRINCIPAL FINANCIAL OFFICER | Sell | 45,225 | $29,848 |
| 2025-08-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, CHIEF FINANCIAL OFFICER | Sell | 1,792 | $1,057 |
| 2025-07-24 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, CHIEF FINANCIAL OFFICER | Sell | 31,866 | $15,296 |
| 2025-05-28 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, CHIEF FINANCIAL OFFICER | Sell | 1,792 | $842 |
| 2025-04-24 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, CHIEF FINANCIAL OFFICER | Sell | 31,866 | $24,855 |
Source: SEC Form 4 filings · as of 2026-02-20